Key result
Genetically engineered mouse models of human arrhythmogenic disorders provide important insights into the molecular mechanisms underlying normal and disordered cardiac conduction.
Answers are grounded in this paper and cite their sources.
This review highlights the utility of genetically engineered mouse models in understanding the molecular mechanisms of human arrhythmogenic disorders.
The mouse has become the principal animal model for studying biologic processes in mammals. Major advances in transgene and gene targeting technology enabled manipulation of the mouse genome in a predictable fashion. Mutant mouse strains provide important insights into the molecular mechanisms underlying normal and disordered cardiac conduction and sudden cardiac death. A variety of mouse strains harboring gene mutations leading to inherited developmental disorders have been designed. Structural protein abnormalities, connexin protein defects, and ion channelopathies associated with human clinical phenotypes, including congenital heart disease, cardiomyopathies, long QT syndrome, and muscular dystrophy, have been engineered into the mouse genome, creating models of human electrophysiologic disease. Functional analyses of the underlying molecular mechanisms of resultant phenotypes require appropriate and sophisticated experimental methodology. In this review, genetic mouse models pertinent to human arrhythmogenic disorders and their application to present-day ex vivo and in vivo murine electrophysiologic technology at the whole organ and animal levels are discussed.
No takes yet. Share an insight, caveat, or question.
Gehrmann et al. (2000) conducted a review in Arrhythmogenic disorders. Genetically engineered mouse models was evaluated. Genetically engineered mouse models of human arrhythmogenic disorders provide important insights into the molecular mechanisms underlying normal and disordered cardiac conduction.
Synapse has enriched 10 related papers. Consider them for comparative context: